All articles by Joshua Silverwood

R3 Vascular secures investigational device exemption for PAD treatment

US-based bioabsorbable scaffold company, R3 Vascular, has been granted investigational device exemption (IDE) approval by the US Food and Drug…
Medable partners with Google to launch clinical trial tracking software

California-based clinical development company Medable has announced a partnership with technology giant Google Cloud to bring the company’s digital, decentralised…
Science Corp brain implant restores patient vision in preliminary trials

US-based brain-computer interface company, Science Corporation, has announced preliminary results from the trial of its PRIMA retina implant, finding the…
MyTomorrows partners with pancreatic cancer pressure group to drive trials

Dutch telehealth company, MyTomorrows, has partnered with multi-stakeholder pressure group Pancreatic Cancer Europe in a bid to drive access to…
Invenio completes enrolment in AI-based lung cancer imaging trial

California-based diagnostic imaging firm, Invenio Imaging, has announced that it has completed enrolment for a pivotal trial of its artificial…

Explainer: Labour has been elected in the UK – now what?

Following the announcement of the UK Labour Party’s near-landslide victory on 5 July, healthcare workers and life science investors have…
UK life science industry optimistically embraces Labour victory

With a Labour party victory across the UK, the UK life sciences industry will be expecting Keir Starmer’s party to…
Mendel sees positive results in AI cohort matching trial

Clinical artificial intelligence (AI) firm, Mendel, has announced results from a trial that found its Neuro-Symbolic system can outperform current…
Reveal Genomics launches HER2+ breast cancer diagnostics trial

Spanish biotech start-up, Reveal Genomics, has announced the launch of a trial evaluating the clinical feasibility of its HER2DX genomic…
Explainer: US Election 2024 -Biden’s healthcare outlook

As a presidential election looms in the US, the incumbent democratic party has made strides to win over public, party…